| ADH5 | alcohol dehydrogenase 5 (also known as GSNOR) |
| AGT | O6-alkylguanine-DNA alkyltransferase (also known as MGMT) |
| ALDH | aldehyde dehydrogenase |
| AMeD | aplastic anemia, mental retardation and dwarfism syndrome |
| AML | acute myeloid leukemia |
| APE1 | apurinic/apyrimidinic endonuclease 1 |
| ATM | ataxia telangiectasia mutated |
| ATP13A3 | adenosine triphosphatase 13A3 |
| ATR | ataxia telangiectasia and Rad3 related |
| 53BP1 | p53 binding protein 1 |
| BRCA | breast cancer gene |
| CHK1 | checkpoint kinase 1 |
| CNA | copy number alteration |
| CRISPR | clustered regularly interspaced short palindromic repeats |
| CSB | Cockayne syndrome B protein |
| DDR | DNA damage response |
| DNA-PKcs | DNA-dependent protein kinase catalytic subunit |
| DPC | DNA-protein crosslink |
| EAC | esophageal adenocarcinoma |
| EGA | European Genome–Phenome Archive |
| ESD | S-formylglutathione hydrolase |
| EXO1 | exonuclease 1 |
| FA | Fanconi anemia |
| FALDH | fatty aldehyde dehydrogenase (ALDH3A2) |
| FANC | Fanconi anemia complementation group |
| FISH | fluorescence in situ hybridization |
| GABA | γ-aminobutyric acid |
| GEO | Gene Expression Omnibus |
| GLO1 | glyoxalase 1 |
| GLO2 | glyoxalase 2 (also known as HAGH) |
| GSH | glutathione |
| GSNO | S-nitrosoglutathione |
| GSNOR | S-nitrosoglutathione reductase (also known as ADH5) |
| GTEx | Genotype-Tissue Expression |
| HAGH | hydroxyacylglutathione hydrolase (also known as GLO2) |
| γH2AX | phosphorylated H2A histone family member X |
| HNSCC | head and neck squamous cell carcinoma |
| 4-HNE | 4-hydroxynonenal |
| HPV | human papillomavirus |
| HR | homologous recombination |
| HSC | hematopoietic stem cell |
| HSPC | hematopoietic stem and progenitor cell |
| IARC | International Agency for Research on Cancer |
| ICL | interstrand crosslink |
| iNOS | inducible nitric oxide synthase |
| LC–MS | liquid chromatography-mass spectrometry |
| MDA | malondialdehyde |
| MG | methylglyoxal |
| MGMT | O6-methylguanine-DNA methyltransferase (also known as AGT) |
| MMR | mismatch repair |
| MLH1 | MutL homolog 1 |
| MSH | MutS homolog |
| MutLα | MutL homolog complex (MLH1–PMS2) |
| MutSα | MutS homolog complex (MSH2–MSH6) |
| NAD+ | nicotinamide adenine dinucleotide |
| NER | nucleotide excision repair |
| OGG1 | 8-oxoguanine DNA glycosylase 1 |
| PARP | poly(ADP-ribose) polymerase |
| PMS2 | postmeiotic segregation increased 2 |
| Polθ | DNA polymerase theta |
| ROS | reactive oxygen species |
| SCC | squamous cell carcinoma |
| SHMT1/2 | serine hydroxymethyltransferase 1/2 |
| SLS | Sjögren–Larsson syndrome |
| SOD | superoxide dismutase |
| TARGET | Therapeutically Applicable Research to Generate Effective Treatments |
| TCA | tricarboxylic acid |
| TCGA | The Cancer Genome Atlas |
| TLS | translesion synthesis |
| TMEJ | Polθ-mediated end joining |
| WT | wildtype |
| XRCC1 | X-ray repair cross-complementing 1 |